| 產(chǎn)品名稱 | Palmitoylethanolamide |
| 產(chǎn)品貨號(hào) | Axon 1211 CAS [544-31-0] MF C18H37NO2MW 299.49 Purity: 98% Soluble in Ethanol Description A putative endocannabinoid; selective GPR55 agonist References Certificates Categories Extra info V di Marzo et al. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem. J. 2001, 358, 249-255. ? S Conti et al. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol. 2002, 135, 181-187. Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation GPR55 A15 Endocannabinoid; GPR55 agonist Chemical name Hexadecanoic acid (2-hydroxy-ethyl)-amide Parent CAS No. [544-31-0] Order Size Unit Price Stock 20 mg €75.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
PalmitoylethanolamideAxon 1211 CAS [544-31-0] MF C18H37NO2
Description
A putative endocannabinoid; selective GPR55 agonist
Endocannabinoid; GPR55 agonist
Chemical nameHexadecanoic acid (2-hydroxy-ethyl)-amide Parent CAS No.[544-31-0] |
| 產(chǎn)品資料 |
